SGC-STK17B-1

N/A

Report date: 2023/09/14 13:35:37
NME

Base Information

Drug NameSGC-STK17B-1
Drug Alias NameSGC-STK17B-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/Threonine Kinase 17b inhibitors
TargetsSerine/Threonine Kinase 17b
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina At Chapel Hill
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A